Clinical Trials Directory

Trials / Completed

CompletedNCT01107431

Effects of a Dietary Supplement Containing L-Arabinose and Trivalent Patented Food-source of Chromium on Blood Glucose and Insulin

A Combination of L-Arabinose and Chromium Lowers Circulating Glucose and Insulin Levels After Acute Oral Sucrose Challenge

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
70 (actual)
Sponsor
Integrative Health Technologies, Inc. · Network
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This study was designed to examine changes in capillary blood glucose and venous insulin levels after a 70 gram oral sucrose challenge with and without simultaneous consumption of a dietary supplement containing L-Arabinose and a patented version of chromium (LA-Cr).

Detailed description

This study concluded that consumption of the LA-Cr supplement in conjunction with a 70-gram sucrose challenge led to a significant reduction of capillary blood glucose and venous insulin as compared to the sucrose challenge without the LA-Cr supplement. This finding may provide an important tool to reduce the adverse effects associated with elevated glucose and insulin levels.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTL-Arabinose and ChromiumConsumed 70 grams of sucrose simultaneously taking a dietary supplement
DIETARY_SUPPLEMENTSucrose without dietary SupplementRepeated measures on subjects taking 70 grams of sucrose along with taking a dietary supplement containing L-Arabinose and Chromium

Timeline

Start date
2008-12-01
Primary completion
2009-12-01
Completion
2009-12-01
First posted
2010-04-21
Last updated
2011-05-13

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01107431. Inclusion in this directory is not an endorsement.